Suspended

CarDiabDiabetic Cardiomyopathy: Diagonostic Value of 2D and 3D Left Ventricular Strains in Echocardiography in Type 2 Diabetic Patients

What is being collected

Data Collection

Who is being recruted

Cardiovascular Diseases+8

+ Diabetes Mellitus

+ Diabetes Mellitus, Type 2

Over 18 Years

+7 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Case-Only

Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.

Observational

Study Start: October 2020

See protocol details

Summary

Principal SponsorUniversity Hospital, Strasbourg, France

Study ContactSamy TALHA, MDMore contacts

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2020

Actual date on which the first participant was enrolled.

Diabetes represents one of the 10 leading causes of death in the world and concerns 5% of the French population (> 3.3 million patients). About 30% of diabetic patients will develop heart failure. The specific and early identification of diabetic cardiomyopathy at a subclinical stage (asymptomatic patients with normal LVEF) will thus make it possible to predict the risk of the onset of heart failure and to strengthen their monitoring and further adapt their treatment.

Official TitleDiabetic Cardiomyopathy: Diagonostic Value of 2D and 3D Left Ventricular Strains in Echocardiography in Type 2 Diabetic Patients

NCT04593173

Principal SponsorUniversity Hospital, Strasbourg, France

Study ContactSamy TALHA, MDMore contacts

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

77 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Case-only

These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Cardiovascular DiseasesDiabetes MellitusDiabetes Mellitus, Type 2Endocrine System DiseasesHeart DiseasesMetabolic DiseasesCardiomyopathiesNutritional and Metabolic DiseasesGlucose Metabolism DisordersDiabetes ComplicationsDiabetic Cardiomyopathies

Criteria

3 inclusion criteria required to participate

Adult patient (≥18 years old)

Type 2 diabetic and hypertensive subjects, cardiac asymptomatic, without myocardial ischemia documented by Dobutamine stress ultrasound (ESD), having at least 1 additional CV risk factor among: dyslipidemia, active or stopped smoking for less than 3 years, family history (1st degree relationship) of major CV accident before age 60, obliterating arteriopathy of the lower limbs and / or carotid atheroma, or proteinuria.

Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

4 exclusion criteria prevent from participating

Patient who expressed his opposition to participating in the study

Valvular heart disease (moderate to severe valve disease), hypertrophic or dilated (MVGi> 95 g / m2 in women and MVGi> 115 g / m2 in men), chronic pulmonary;

History of cardiotoxic chemotherapy;

Subject under legal protection, under guardianship or under guardianship.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Service de Physiologie et d'Explorations Fonctionnelles

Strasbourg, FranceOpen Service de Physiologie et d'Explorations Fonctionnelles in Google Maps

SuspendedOne Study Center